Get the Latest Scientific News
Sign up for latest scientific news and use cases in biomedical research.
News & Updates
NMR Metabolomics Analysis of Population-Based Cohorts to Enable Preventive Healthcare
THL Biobank use case: To validate the use of their NMR spectroscopy technique in accurate prediction of risk for common diseases, such as heart disease, and preventive healthcare, Nightingale Health Ltd has analyzed serum samples from 40,000 sample donors of THL Biobank.
Genome Data Returned to the Finnish Biobanks Is a Valuable Resource for Healthcare Research Projects
Large genome data collections are important for the effects of genes to begin to show in analyses. Therefore, genome data returned to the biobanks from research projects such as FinnGen and available via Fingenious service are of utmost importance for new scientific discoveries.
FINBB and Finnish Biobanks Announce a Collaboration with Bayer on the Use of Finnish Biobank Samples, Biodata and Services
Finnish biobanks and Finnish Biobank Cooperative - FINBB have initiated a collaboration with Bayer AG enabling the global use of biobank samples in Bayer’s medical research. The aim of the collaboration is the mutual interest to enhance medical research and product development.
Fingenious® Serves Researchers in Three Steps
Browse biobank collections
By registering you can access the free electronic Fingenious® ICD-10 Catalogue to browse biobank sample and data collections at aggregate-level.
Sample and data availability
After registering fill in Fingenious® Feasibility request to obtain more detailed information about the sample and data availability at Finnish biobanks.
Access samples and data
Proceed to Fingenious® Access request: one centralized service for an access to Finnish public biobanks requiring just one contract for the researcher.
Biobank Collections and Services
You can access the Finnish public biobanks through Fingenious®portal:
Access to >11 million samples consisting of blood, FFPE and DNA samples, fresh frozen tissue and liquid biopsies.
Phenotype data, such as clinical health record data, can be provided together with the samples.
The genetic data analyzed in biobank studies, such as FinnGen, is returned to and available at the biobanks.
Finding study participants
Possibility to recontact consented sample donors via biobanks for further biomedical studies.
Breakthroughs in disease prevention, diagnosis and treatment
Why Choose Finland for Your Biomedical Research?
Well-functioning healthcare system
The entire population is covered with longitudinal electronic health records and a personal identification code that enables linking of the biobank samples to deep phenotypic data.
World-class genomic data
The FinnGen research project produces genotype data returning back to the biobanks where it can be combined with deep phenotypic data.
Research-advancing Biobank Act has been in force since 2013. Act on the Secondary Use of Health and Social Data has been in force since May 2019 and a proposal for the Genome Act is in preparation.
A national commitment
Finnish government drives innovation in personalized medicine, with a biobank ecosystem at its core.
Finns trust researchers and are willing to participate in public screening programs and donate
their samples to biobanks.
Study participant finding
Sample donors with a prior consent can be contacted for further biomedical studies.